Stay updated on Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial

Sign up to get notified when there's something new on the Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer now displays ClinicalTrials.gov release v3.8.0 instead of v3.7.2. Study record details are unchanged.
    Difference
    0.1%
    Check dated 2026-11-02T23:41:07.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A sitewide NIH banner announces updates and FAQs about the transition from “Artificial Intelligence” to “Super Intelligence” terminology.
    Difference
    0.4%
    Check dated 2026-10-26T23:18:12.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The footer's site revision indicator changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-19T23:46:18.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision indicator changed from v3.7.0 to v3.7.1; the study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-13T05:42:23.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The study history now includes additions of Adverse Events, Outcome Measures (Results), Baseline Characteristics, and Participant Flow as part of the Document Section updates, tied to revision v3.7.0 (38) around 2026-09-15 to 2026-09-18.
    Difference
    0.9%
    Check dated 2026-09-21T23:46:52.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    New revision label v3.6.6 appears in the record history, and the previous revision v3.6.5 is removed. This indicates the study record history has been updated to reflect the latest version of the record.
    Difference
    0.1%
    Check dated 2026-08-31T18:28:59.000Z thumbnail image

Stay in the know with updates to Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial page.